期刊文献+

慢性阻塞性肺疾病预后因素和死亡预测因子 被引量:13

Predictors of prognosis and mortality in chronic obstructive pulmonary disease
原文传递
导出
摘要 慢性阻塞性肺疾病(chronic obstructive pulmonary disease, COPD)是一种人类的主要慢性疾病和死亡病因,目前已上升为人类致死病因的第四位。据预测在未来10年中COPD的发病率和致死率将进一步增高。近年来,许多有关的预后和死亡预测因子的众多指标成为目前国内外研究的热点,但由于不同研究者所采取的研究方式和角度不同,所得出的结论并不完全一致。以下即对各观点作一简要综述。 Chronic obstructive pulmonary disease(COPD) is a significant worldwide chronic disease of human beings, which has become the fourth leading cause of death. It is estimated that the morbidity and mortality caused by COPD will be increasing in next decade. Now many authors have investigated the predictors of prognosis and mortality in COPD from several aspects. However, the studies have shown conflicting results due to their different methods and points of view. We'll make a summary about those variant viewpoints as follow.
出处 《国际呼吸杂志》 2007年第4期270-273,共4页 International Journal of Respiration
关键词 慢性阻塞性肺疾病 预后因素 病死率 Chronic obstructive pulmonary disease Prognosis Mortality
  • 相关文献

参考文献27

  • 1Viegi G, Scognamiglio A, Baldacci S, et al. Epidemiology of chronic obstructive pulmonary disease (COPD). Respiration,2001,68:4-19.
  • 2Matheson M, Benke G, Raven J, et al. Biological dust exposure in the workplace is a risk factor for chronic obstructive pulmonary disease. Thorax, 2005,60 : 645-651.
  • 3Yeo J, Mensforth A, Karimova G, et al. Co-morbidity in the elderly with COPD-its impact on health service utilization and quality of life, a community study. Age Ageing, 2005,34 : 35.
  • 4Raguso C, Guinot S, Janssens JP, et al. Chronic hypoxia:common traits between chronic obstructive pulmonary disease and altitude. Cur Opin Clin Nutr Metab Care,2004,7:411-417.
  • 5Sandek K, Bratel T, Hellstrom G, et al. Ventilation-perfusion inequality and carbon dioxide sensitivity in hypoxaemic chronic obstructive pulmonary disease (COPD) and effects of 6 months of long-term oxygen treatment (LTOT). Clin Physiol,2001,21 :584-593.
  • 6Yilmaz R, Gencer M, Ceylan E, et al. Impact of chronic obstructive pulmonary disease with pulmonary hypertension on both left ventricular systolic and diastolic performance. J Am Soc Echocard, 2005,18 : 873-881.
  • 7Wright JL,Levy RD,Churg A,et al. Pulmonary hypertension in chronic obstructive pulmonary disease: current theories of pathogenesis and their implications for treatment. Thorax,2005,60:605-609.
  • 8Sin DD, Man SFP. Inhaled corticosteroids and survival in chronic obstructive pulmonary disease:does the dose matter? Eur Respir J, 2003,21:260-266.
  • 9Sin DD, Jack V, Tu JV. Inhaled corticosteroids and risk and mortality and readmission in elderly patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med,2001,164 : 580-584.
  • 10So riano JB, Vestbo J, Pride NB, et al. Survival in COPD patients after regular use of fluticasone propionate and salmeterol in general practice. Eur Respir J, 2002,20 : 819-825.

同被引文献149

引证文献13

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部